These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 25424433)

  • 1. "Glial inhibition" of memory in Alzheimer's disease.
    Yuan TF; Shan C
    Sci China Life Sci; 2014 Dec; 57(12):1238-40. PubMed ID: 25424433
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations of the blood-brain barrier and glial cells in white matter lesions in cerebrovascular and Alzheimer's disease patients.
    Leys D; Hénon H; Pasquier F
    Stroke; 1997 Apr; 28(4):874-6. PubMed ID: 9099213
    [No Abstract]   [Full Text] [Related]  

  • 3. Glial reaction in aging and Alzheimer's disease.
    Unger JW
    Microsc Res Tech; 1998 Oct; 43(1):24-8. PubMed ID: 9829455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Neuroglia in Alzheimer's Disease: From Cohort to Contestant in the Disease Progression and its Therapy.
    Toledano A; Merino JJ; Rodríguez JJ
    Curr Alzheimer Res; 2016; 13(4):318-20. PubMed ID: 27018260
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control.
    Salmina AB; Inzhutova AI; Malinovskaya NA; Petrova MM
    J Alzheimers Dis; 2010; 22(1):17-36. PubMed ID: 20847414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurono-glial ratios in the frontal cortex of the human cerebrum in normal and pathologic aging (Alzheimer's disease)].
    Orzhekhovskaia NS
    Arkh Anat Gistol Embriol; 1986 Nov; 91(11):5-12. PubMed ID: 3813909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-glia interactions as therapeutic targets in neurodegeneration.
    Salmina AB
    J Alzheimers Dis; 2009; 16(3):485-502. PubMed ID: 19276541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are paradoxical cell cycle activities in neurons and glia related to the metabolic theory of Alzheimer's disease?
    Erol A
    J Alzheimers Dis; 2010; 19(1):129-35. PubMed ID: 20061632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetically regulated microRNAs in Alzheimer's disease.
    Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
    Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Ki67, PCNA and the chromosome replication licensing protein Mcm2 in glial cells of the ageing human hippocampus increases with the burden of Alzheimer-type pathology.
    Wharton SB; Williams GH; Stoeber K; Gelsthorpe CH; Baxter L; Johnson AL; Ince PG;
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):33-8. PubMed ID: 15936508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of globular glial tauopathy presenting clinically as alzheimer disease.
    SantaCruz KS; Rottunda SJ; Meints JP; Bearer EL; Bigio EH; McCarten JR
    Alzheimer Dis Assoc Disord; 2015; 29(1):82-4. PubMed ID: 23751368
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amygdala cell loss and atrophy in Alzheimer's disease.
    Scott SA; DeKosky ST; Sparks DL; Knox CA; Scheff SW
    Ann Neurol; 1992 Oct; 32(4):555-63. PubMed ID: 1456740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implicit memory and Alzheimer's disease neuropathology.
    Fleischman DA; Wilson RS; Gabrieli JD; Schneider JA; Bienias JL; Bennett DA
    Brain; 2005 Sep; 128(Pt 9):2006-15. PubMed ID: 15975947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
    Harris CD; Ermak G; Davies KJ
    FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease.
    Honig LS; Chin SS
    Sci Aging Knowledge Environ; 2001 Oct; 2001(1):dn2. PubMed ID: 14602942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine cognitive dysfunction and the cerebellum: acetylcholinesterase reduction, neuronal and glial changes.
    Pugliese M; Gangitano C; Ceccariglia S; Carrasco JL; Del Fà A; Rodríguez MJ; Michetti F; Mascort J; Mahy N
    Brain Res; 2007 Mar; 1139():85-94. PubMed ID: 17292335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of cholesterol, amyloid and glia in Alzheimer's disease transgenic mouse brain tissue using time-of-flight secondary ion mass spectrometry (ToF-SIMS) and immunofluorescence imaging.
    Solé-Domènech S; Sjövall P; Vukojević V; Fernando R; Codita A; Salve S; Bogdanović N; Mohammed AH; Hammarström P; Nilsson KP; LaFerla FM; Jacob S; Berggren PO; Giménez-Llort L; Schalling M; Terenius L; Johansson B
    Acta Neuropathol; 2013 Jan; 125(1):145-57. PubMed ID: 22996963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth.
    Canning DR; McKeon RJ; DeWitt DA; Perry G; Wujek JR; Frederickson RC; Silver J
    Exp Neurol; 1993 Dec; 124(2):289-98. PubMed ID: 8287928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.
    Dei R; Takeda A; Niwa H; Li M; Nakagomi Y; Watanabe M; Inagaki T; Washimi Y; Yasuda Y; Horie K; Miyata T; Sobue G
    Acta Neuropathol; 2002 Aug; 104(2):113-22. PubMed ID: 12111353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.